← Eichor
Study identifier: NCT06289049 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Heavy Strength Training in Head and Neck Cancer Survivors

Condition: Head and Neck Neoplasms · Head and Neck Cancer · Head and Neck Squamous Cell Carcinoma  ·  Sponsor: University of Alberta

PhasePhase 2
Planned participants60
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Despite improvements in treatments, head and neck cancer survivors (HNCS) still endure acute and chronic side effects such as loss of muscular strength, limitations in physical functioning, fatigue, and swallowing difficulties that impact quality of life (QoL) and limit return to work. Light-to-moderate intensity strength training (LMST) has been shown to improve some side effects. Heavy lifting strength training (HLST) may further improve outcomes in some populations, however, only one small pilot study has focused on HNCS. The LIFTING 2 trial will be the first to examine the feasibility and effects of a HLST program versus no exercise in HNCS.

This description comes directly from the study's public registry record.

Talk to the study team

Stephanie Ntoukas  ·  7804922829  ·  ntoukas@ualberta.ca

Always discuss trial participation with your own doctor first.

Locations (1)

University of AlbertaEdmonton, Alberta, CanadaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06289049